Annual long term liabilities:
$845.57M+$472.64M(+126.73%)Summary
- As of today (June 22, 2025), ARWR annual total long term liabilities is $845.57 million, with the most recent change of +$472.64 million (+126.73%) on September 30, 2024.
- During the last 3 years, ARWR annual long term liabilities has risen by +$690.78 million (+446.27%).
- ARWR annual long term liabilities is now at all-time high.
Performance
ARWR Long term liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly long term liabilities:
$668.73M-$195.13M(-22.59%)Summary
- As of today (June 22, 2025), ARWR quarterly total long term liabilities is $668.73 million, with the most recent change of -$195.13 million (-22.59%) on March 31, 2025.
- Over the past year, ARWR quarterly long term liabilities has increased by +$274.16 million (+69.48%).
- ARWR quarterly long term liabilities is now -22.59% below its all-time high of $863.86 million, reached on December 31, 2024.
Performance
ARWR quarterly long term liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Long term liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
ARWR Long term liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +126.7% | +69.5% |
| 3 y3 years | +446.3% | +494.7% |
| 5 y5 years | +9576.4% | +4616.4% |
ARWR Long term liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +527.5% | -22.6% | +494.7% |
| 5 y | 5-year | at high | +9576.4% | -22.6% | +4616.4% |
| alltime | all time | at high | >+9999.0% | -22.6% | >+9999.0% |
ARWR Long term liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $668.73M(-22.6%) |
| Dec 2024 | - | $863.86M(+2.2%) |
| Sep 2024 | $845.57M(+126.7%) | $845.57M(+88.7%) |
| Jun 2024 | - | $448.07M(+13.6%) |
| Mar 2024 | - | $394.57M(+1.5%) |
| Dec 2023 | - | $388.85M(+4.3%) |
| Sep 2023 | $372.93M(+176.8%) | $372.93M(+8.5%) |
| Jun 2023 | - | $343.64M(+1.4%) |
| Mar 2023 | - | $339.05M(-9.1%) |
| Dec 2022 | - | $373.11M(+176.9%) |
| Sep 2022 | $134.75M(-12.9%) | $134.75M(-9.8%) |
| Jun 2022 | - | $149.39M(+32.9%) |
| Mar 2022 | - | $112.45M(-12.8%) |
| Dec 2021 | - | $128.95M(-16.7%) |
| Sep 2021 | $154.79M(+672.3%) | $154.79M(+50.9%) |
| Jun 2021 | - | $102.60M(-28.8%) |
| Mar 2021 | - | $144.06M(+631.8%) |
| Dec 2020 | - | $19.68M(-1.8%) |
| Sep 2020 | $20.04M(+129.4%) | $20.04M(-1.6%) |
| Jun 2020 | - | $20.36M(+43.6%) |
| Mar 2020 | - | $14.18M(-1.4%) |
| Dec 2019 | - | $14.38M(+64.5%) |
| Sep 2019 | $8.74M(+118.2%) | $8.74M(-63.7%) |
| Jun 2019 | - | $24.07M(-23.6%) |
| Mar 2019 | - | $31.49M(-9.6%) |
| Dec 2018 | - | $34.84M(+770.0%) |
| Sep 2018 | $4.00M(-10.1%) | $4.00M(-0.3%) |
| Jun 2018 | - | $4.02M(-3.4%) |
| Mar 2018 | - | $4.16M(-3.4%) |
| Dec 2017 | - | $4.30M(-3.3%) |
| Sep 2017 | $4.45M(-40.7%) | $4.45M(-14.7%) |
| Jun 2017 | - | $5.22M(-12.8%) |
| Mar 2017 | - | $5.98M(-40.5%) |
| Dec 2016 | - | $10.05M(+33.9%) |
| Sep 2016 | $7.51M(+11.3%) | $7.51M(-33.4%) |
| Jun 2016 | - | $11.27M(+70.1%) |
| Mar 2016 | - | $6.62M(-0.9%) |
| Dec 2015 | - | $6.68M(-0.9%) |
| Sep 2015 | $6.75M(+35.3%) | $6.75M(+37.3%) |
| Jun 2015 | - | $4.91M(-1.2%) |
| Mar 2015 | - | $4.97M(+0.9%) |
| Dec 2014 | - | $4.93M(-1.1%) |
| Sep 2014 | $4.98M(+73.7%) | $4.98M(+94.3%) |
| Jun 2014 | - | $2.56M(-2.1%) |
| Mar 2014 | - | $2.62M(-5.2%) |
| Dec 2013 | - | $2.76M(-3.7%) |
| Sep 2013 | $2.87M(+20.0%) | $2.87M(+90.7%) |
| Jun 2013 | - | $1.50M(+0.7%) |
| Mar 2013 | - | $1.49M(-3.5%) |
| Dec 2012 | - | $1.55M(-35.2%) |
| Sep 2012 | $2.39M | $2.39M(+7.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2012 | - | $2.22M(+4.0%) |
| Mar 2012 | - | $2.14M(-5.1%) |
| Dec 2011 | - | $2.25M(+203.5%) |
| Sep 2011 | $742.40K(>+9900.0%) | $742.40K(+32.4%) |
| Jun 2011 | - | $560.90K(+7.9%) |
| Mar 2011 | - | $519.70K(>+9900.0%) |
| Dec 2010 | - | $0.00(0.0%) |
| Sep 2010 | $0.00(-100.0%) | $0.00(0.0%) |
| Jun 2010 | - | $0.00(0.0%) |
| Mar 2010 | - | $0.00(0.0%) |
| Dec 2009 | - | $0.00(-100.0%) |
| Sep 2009 | $500.00K(-59.2%) | $500.00K(-53.5%) |
| Jun 2009 | - | $1.07M(-79.8%) |
| Mar 2009 | - | $5.31M(-3.9%) |
| Dec 2008 | - | $5.53M(+350.9%) |
| Sep 2008 | $1.23M(+145.3%) | $1.23M(+145.3%) |
| Jun 2008 | - | $500.00K(0.0%) |
| Mar 2008 | - | $500.00K(0.0%) |
| Dec 2007 | - | $500.00K(0.0%) |
| Sep 2007 | $500.00K(>+9900.0%) | $500.00K(>+9900.0%) |
| Jun 2007 | - | $0.00(0.0%) |
| Mar 2007 | - | $0.00(0.0%) |
| Dec 2006 | - | $0.00(0.0%) |
| Sep 2006 | $0.00(0.0%) | $0.00(0.0%) |
| Jun 2006 | - | $0.00(0.0%) |
| Mar 2006 | - | $0.00(0.0%) |
| Dec 2005 | - | $0.00(0.0%) |
| Sep 2005 | $0.00(0.0%) | $0.00(0.0%) |
| Jun 2005 | - | $0.00(0.0%) |
| Mar 2005 | - | $0.00(0.0%) |
| Dec 2004 | - | $0.00(0.0%) |
| Sep 2004 | $0.00(-100.0%) | $0.00(0.0%) |
| Jun 2004 | - | $0.00(-100.0%) |
| Jun 2003 | - | $27.50K(0.0%) |
| Mar 2003 | - | $27.50K(+5.8%) |
| Dec 2002 | - | $26.00K(-5.5%) |
| Sep 2002 | $27.50K(-16.7%) | $27.50K(-5.2%) |
| Jun 2002 | - | $29.00K(-4.9%) |
| Mar 2002 | - | $30.50K(-4.7%) |
| Dec 2001 | - | $32.00K(-3.0%) |
| Sep 2001 | $33.00K(-15.4%) | $33.00K(-4.3%) |
| Jun 2001 | - | $34.50K(-4.2%) |
| Mar 2001 | - | $36.00K(-4.0%) |
| Dec 2000 | - | $37.50K(-3.8%) |
| Sep 2000 | $39.00K(-9.3%) | $39.00K(-3.7%) |
| Jun 2000 | - | $40.50K(+3.8%) |
| Mar 2000 | - | $39.00K(-1.3%) |
| Dec 1999 | - | $39.50K |
| Sep 1999 | $43.00K(-4.4%) | - |
| Sep 1998 | $45.00K(>+9900.0%) | - |
| Sep 1997 | $0.00 | - |
FAQ
- What is Arrowhead Pharmaceuticals annual total long term liabilities?
- What is the all time high annual long term liabilities for Arrowhead Pharmaceuticals?
- What is Arrowhead Pharmaceuticals annual long term liabilities year-on-year change?
- What is Arrowhead Pharmaceuticals quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Arrowhead Pharmaceuticals?
- What is Arrowhead Pharmaceuticals quarterly long term liabilities year-on-year change?
What is Arrowhead Pharmaceuticals annual total long term liabilities?
The current annual long term liabilities of ARWR is $845.57M
What is the all time high annual long term liabilities for Arrowhead Pharmaceuticals?
Arrowhead Pharmaceuticals all-time high annual total long term liabilities is $845.57M
What is Arrowhead Pharmaceuticals annual long term liabilities year-on-year change?
Over the past year, ARWR annual total long term liabilities has changed by +$472.64M (+126.73%)
What is Arrowhead Pharmaceuticals quarterly total long term liabilities?
The current quarterly long term liabilities of ARWR is $668.73M
What is the all time high quarterly long term liabilities for Arrowhead Pharmaceuticals?
Arrowhead Pharmaceuticals all-time high quarterly total long term liabilities is $863.86M
What is Arrowhead Pharmaceuticals quarterly long term liabilities year-on-year change?
Over the past year, ARWR quarterly total long term liabilities has changed by +$274.16M (+69.48%)